HK1209421A1 - Bicyclic heteroaryl cycloalkyldiamine derivatives as inhibitors of spleen tyrosine kinases (syk) - Google Patents

Bicyclic heteroaryl cycloalkyldiamine derivatives as inhibitors of spleen tyrosine kinases (syk)

Info

Publication number
HK1209421A1
HK1209421A1 HK15110057.2A HK15110057A HK1209421A1 HK 1209421 A1 HK1209421 A1 HK 1209421A1 HK 15110057 A HK15110057 A HK 15110057A HK 1209421 A1 HK1209421 A1 HK 1209421A1
Authority
HK
Hong Kong
Prior art keywords
syk
inhibitors
tyrosine kinases
bicyclic heteroaryl
spleen tyrosine
Prior art date
Application number
HK15110057.2A
Other languages
English (en)
Chinese (zh)
Inventor
Gebhard Thoma
Peter Buehlmayer
Maurice Van Eis
Alexander Baxter Smith
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1209421A1 publication Critical patent/HK1209421A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK15110057.2A 2012-08-13 2015-10-14 Bicyclic heteroaryl cycloalkyldiamine derivatives as inhibitors of spleen tyrosine kinases (syk) HK1209421A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261682392P 2012-08-13 2012-08-13
PCT/IB2013/056589 WO2014027300A1 (en) 2012-08-13 2013-08-12 Bicyclic heteroaryl cycloalkyldiamine derivatives as inhibitors of spleen tyrosine kinases (syk)

Publications (1)

Publication Number Publication Date
HK1209421A1 true HK1209421A1 (en) 2016-04-01

Family

ID=49385306

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15110057.2A HK1209421A1 (en) 2012-08-13 2015-10-14 Bicyclic heteroaryl cycloalkyldiamine derivatives as inhibitors of spleen tyrosine kinases (syk)

Country Status (14)

Country Link
US (2) US9315500B2 (ko)
EP (1) EP2882747B1 (ko)
JP (1) JP6236083B2 (ko)
KR (1) KR20150042256A (ko)
CN (1) CN104520297B (ko)
AU (1) AU2013303824B2 (ko)
BR (1) BR112015003058A2 (ko)
CA (1) CA2880790C (ko)
EA (1) EA201590372A1 (ko)
ES (1) ES2576692T3 (ko)
HK (1) HK1209421A1 (ko)
IN (1) IN2015DN00950A (ko)
MX (1) MX2015002006A (ko)
WO (1) WO2014027300A1 (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015003058A2 (pt) * 2012-08-13 2017-07-04 Novartis Ag derivados bicíclicos de heteroaril cicloalquildiamina como inibidores de tirosina quinases do baço (syk)
EP3942045A1 (en) 2019-03-21 2022-01-26 Onxeo A dbait molecule in combination with kinase inhibitor for the treatment of cancer
EP4054579A1 (en) 2019-11-08 2022-09-14 Institut National de la Santé et de la Recherche Médicale (INSERM) Methods for the treatment of cancers that have acquired resistance to kinase inhibitors
WO2021148581A1 (en) 2020-01-22 2021-07-29 Onxeo Novel dbait molecule and its use
AU2023232562A1 (en) 2022-03-08 2024-09-05 Equashield Medical Ltd Fluid transfer station in a robotic pharmaceutical preparation system

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1524747A (en) 1976-05-11 1978-09-13 Ici Ltd Polypeptide
ATE28864T1 (de) 1982-07-23 1987-08-15 Ici Plc Amide-derivate.
GB9721069D0 (en) 1997-10-03 1997-12-03 Pharmacia & Upjohn Spa Polymeric derivatives of camptothecin
CA2514733A1 (en) 2003-02-28 2004-09-16 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
KR100781704B1 (ko) * 2005-04-20 2007-12-03 에스케이케미칼주식회사 피리딘 유도체와 이의 제조방법, 및 이를 포함하는약제조성물
JP2009530342A (ja) * 2006-03-20 2009-08-27 エフ．ホフマン−ラ ロシュ アーゲー Ｂｔｋおよびｓｙｋ蛋白キナーゼを阻害する方法
TW200938542A (en) 2008-02-01 2009-09-16 Irm Llc Compounds and compositions as kinase inhibitors
EP2459558A2 (en) * 2009-07-30 2012-06-06 Irm Llc Compounds and compositions as syk kinase inhibitors
TW201105669A (en) * 2009-07-30 2011-02-16 Irm Llc Compounds and compositions as Syk kinase inhibitors
EP2493313B1 (en) * 2009-10-29 2017-12-13 Genosco Kinase inhibitors
WO2012097479A1 (en) * 2011-01-21 2012-07-26 Abbott Laboratories Bicyclic inhibitors of anaphastic lymphoma kinase
BR112015003058A2 (pt) * 2012-08-13 2017-07-04 Novartis Ag derivados bicíclicos de heteroaril cicloalquildiamina como inibidores de tirosina quinases do baço (syk)

Also Published As

Publication number Publication date
CN104520297B (zh) 2016-08-24
KR20150042256A (ko) 2015-04-20
EP2882747A1 (en) 2015-06-17
BR112015003058A2 (pt) 2017-07-04
ES2576692T3 (es) 2016-07-08
CA2880790C (en) 2020-09-08
EA201590372A1 (ru) 2015-05-29
US20160213670A1 (en) 2016-07-28
EP2882747B1 (en) 2016-04-27
AU2013303824B2 (en) 2016-03-31
CN104520297A (zh) 2015-04-15
JP2015524838A (ja) 2015-08-27
WO2014027300A1 (en) 2014-02-20
JP6236083B2 (ja) 2017-11-22
CA2880790A1 (en) 2014-02-20
US20150218157A1 (en) 2015-08-06
AU2013303824A1 (en) 2015-02-26
IN2015DN00950A (ko) 2015-06-12
US9315500B2 (en) 2016-04-19
MX2015002006A (es) 2015-06-02

Similar Documents

Publication Publication Date Title
IL263262B (en) Atr kinase inhibitor compounds, preparations containing them, their uses and methods for their preparation
ZA201600648B (en) Novel pyrrolopyrimidine compounds as inhibitors of protein kinases
HK1208026A1 (en) Heteroaryl inhibitors of pde4 pde4
HK1215578A1 (zh) 作為蛋白激酶抑制劑的氮雜吲哚衍生物
EP2863916A4 (en) SUBSTITUTED PYRIDINE MILK TYROSINE CHINASE INHIBITORS
EP2931281A4 (en) SPINENIC TYROSINE KINASE INHIBITORS CONTAINING AMINOPYRIDINE
EP2916836A4 (en) AMINOPYRIDE-CONTAINING MILK TYROSINE KINASE (SYK) INHIBITOR
SI2880035T1 (sl) Nove spojine pirolopirimidina kot inhibitorji protein kinaz
EP2884982A4 (en) SUBSTITUTED RATE (SYK) PHENYL TYROSINE KINASE INHIBITORS
HK1216751A1 (zh) 可用作脾酪氨酸激酶 抑制劑的吡啶基-和吡嗪基-甲基氧基-芳基衍生物
HK1209421A1 (en) Bicyclic heteroaryl cycloalkyldiamine derivatives as inhibitors of spleen tyrosine kinases (syk)
EP2948456A4 (en) BICYCLIC PYRIMIDONE COMPOUNDS AS LP-PLA2 INHIBITORS